Pegaspargase Combined with Concurrent Radiotherapy for Early‐Stage Extranodal Natural Killer/T‐Cell Lymphoma, Nasal Type: A Two‐Center Phase II Study

BACKGROUND: Concurrent chemoradiotherapy (CCRT) is expected to improve local and systemic disease control and has been established as a standard therapy for several types of solid tumors. Considering the benefits of frontline radiation and pegaspargase in localized extranodal natural killer (NK)/T‐c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hua, Wang, Liang, Li, Chun, Wuxiao, Zhijun, Chen, Guanjun, Luo, Wei, Lu, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Hematologic Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648361/
https://www.ncbi.nlm.nih.gov/pubmed/32627928
http://dx.doi.org/10.1634/theoncologist.2020-0144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648361/
https://www.ncbi.nlm.nih.gov/pubmed/32627928
http://dx.doi.org/10.1634/theoncologist.2020-0144

Ejemplares similares